SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure and volatility as investors weigh the impact of an ongoing OpenAI-related legal battle against the company's broader AI integration and cloud infrastructure strategy. While community sentiment remains divided between those viewing the current price weakness as a long-term accumulation opportunity and those frustrated by its relative underperformance compared to other mega-cap tech, active discussions highlight a rotation toward software monetization and potential catalysts from upcoming legal proceedings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is rallying to record highs as reports of U.S. approval for advanced chip sales to major Chinese firms alleviate long-standing trade concerns. The community is actively debating whether this momentum will carry the stock toward higher valuation milestones ahead of next week's earnings or if the rapid price appreciation has created a precarious bubble.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility as traders debate whether the current price action signals a healthy cooling period or a structural collapse for the overbought semiconductor sector. The community is sharply divided, with bulls aggressively buying the dip on AI growth narratives, while bears point to extreme technical valuations and the potential for a deeper, long-term retracement.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending after President Trump announced a deal for China to purchase 200 Boeing jets, a move that has fueled community debate over whether the order size fell short of high market expectations or represents a significant thawing of trade relations. While some investors view the deal as a major catalyst for long-term recovery and cash flow, others are expressing frustration over the stock's volatility and the influence of hedge fund positioning on the price action.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is seeing intense market activity driven by a strategic $100 million investment from the Winklevoss Capital Fund, alongside better-than-expected quarterly revenue figures and growth in its card services. Investors are actively debating the potential for a short squeeze due to high short interest, while community discussions remain divided between speculative bullishness regarding potential Russell 2000 inclusion and concerns over the company's long-term financial health and legal challenges.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intense selling pressure and hitting multi-year lows, fueled by a proxy battle involving the founder, leadership transition uncertainty, and broader concerns over slowing North American growth. While many investors express frustration over the sustained downtrend, a vocal segment of the community is aggressively buying the dip, citing deep-value P/E multiples and the company's strong cash position as indicators of an impending reversal.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is facing significant volatility as investors weigh disappointing Q1 earnings and production delays against a massive long-term growth narrative fueled by government contracts and critical mineral demand. While the stock has seen a sharp pullback, the community remains deeply divided between those betting on a major squeeze driven by high short interest and institutional accumulation, and skeptics who are increasingly frustrated by the company's inconsistent operational execution.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is trending as investors react to the company securing over $4 million in U.S. government contracts for quantum materials and laser technology, which the community views as a critical step toward commercial validation. While some traders are focused on the stock's significant short interest and potential for a squeeze, others are debating whether this new funding provides sufficient momentum to overcome skepticism regarding the company's path to scalable manufacturing.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are weighing geopolitical tensions and rising bond yields against high-profile trade optimism following summit meetings in Beijing. Community discussion is heavily divided, with some traders anticipating a technical correction or 'V-shaped' recovery, while others express caution over stretched equity valuations and potential volatility surrounding monthly options expiration.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of +15.79% and +25.85%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

<ul class="summary-bullets"><li>Vascular surgeons Dr. Patrick Geraghty and Dr. Patrick Muck — who led the earlier study — will head the new trial.</li><li>Separately, the company also announced that it has initiated a voluntary recall in the U.S. for its CGuard Prime 135 cm carotid stent delivery system.</li><li>The company also withdrew its full-year 2026 revenue guidance.</li></ul>&nbsp;Shares of InspireMD (NSPR) jumped 30% after hours on Friday after the company announced that the U.S. Food and Drug Administration has approved its application to start the CGUARDIANS III pivotal study of the SwitchGuard Neuro-Protection System, overshadowing the pessimism around the firm dropping its 2026 financial guidance.The trial will test the safety and effectiveness of SwitchGuard when used with the company’s CGuard Prime carotid stent during transcarotid artery revascularization or TCAR procedures. The device reverses blood flow to catch debris and help prevent strokes in patients with carotid artery disease.Vascular surgeons Dr. Patrick Geraghty and Dr. Patrick Muck — who led the earlier study — will head the new trial.“This is an important step toward offering a complete TCAR solution,” said CEO Marvin Slosman. The company hopes to launch SwitchGuard in the U.S. in 2027 if approved.InspireMD already won FDA approval for its CGuard Prime stent in June 2025.<h2 class="st-heading-2">Recall And Dropped Guidance</h2>Separately, the company also announced that it has initiated a voluntary recall in the U.S. for its CGuard Prime 135 cm carotid stent delivery system.The company said the delivery system did not meet technical performance expectations during a controlled commercial launch for carotid artery stenting (CAS) procedures. The recall applies only to the delivery system and does not affect the CGuard stent implant itself.There are no safety concerns for patients who have already received the implanted stent. InspireMD is pausing U.S. sales of the 135 cm version while it makes design improvements. The company expects FDA approval for the original CGuard delivery system in the third quarter of 2026 and for the enhanced Prime version in the first half of 2027. As a result, it has withdrawn its full-year 2026 revenue guidance.“Management believes this is the most prudent step given the impact of the temporary discontinuation of commercial activity in the U.S. pending the anticipated FDA approval of its original CGuard stent delivery system in the third quarter of 2026,” the company said.More details will be provided at the company’s first quarter earnings on May 4, InspireMD added.<h2 class="st-heading-2">How Did NSPR Retail Traders React?</h2>On Stocktwits, retail sentiment around NSPR stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume remained at ‘normal’ levels.A Stocktwits user expressed skepticism about upcoming dilution.<stembedurl>https://www.stocktwits.com/Thespectator/message/652062806</stembedurl>Another user dismissed the application news as nothing more than regular updates from biotech companies.<stembedurl>https://www.stocktwits.com/vcaelum/message/652062730</stembedurl><a href="https://stocktwits.com/symbol/NSPR">NSPR stock</a> has fallen 56% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-uone-stock-rally-38-percent-today/cZQVLLCReeY">Why Did UONE Stock Rally 38% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Shares of Beam Global rose premarket on Thursday. (Representative image: Getty Images)

NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance

The trial will test the safety and effectiveness of SwitchGuard when used with the company’s CGuard Prime carotid stent during transcarotid artery revascularization or TCAR procedures.

Equity

The trial will test the safety and effectiveness of SwitchGuard when used with the company’s CGuard Prime carotid stent during transcarotid artery revascularization or TCAR procedures.


InspireMD (NYSE:NSPR) Stock Price Up 3.5% - What's Next?

InspireMD (NYSE:NSPR) Stock Price Up 3.5% - Here's What Happened...

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)

InspireMD (NSPR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

InspireMD (NYSE:NSPR) Trading Down 6.7% - What's Next?

InspireMD (NYSE:NSPR) Shares Down 6.7% - Time to Sell...

InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates

InspireMD (NSPR) delivered earnings and revenue surprises of +36.36% and +14.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

921,587 Shares in InspireMD, Inc. $NSPR Purchased by Ghisallo Capital Management LLC

Ghisallo Capital Management LLC purchased a new position in InspireMD, Inc. (NYSE:NSPR - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...

Rosalind Advisors Inc. Purchases 1,616,644 Shares of InspireMD, Inc. $NSPR

Rosalind Advisors Inc. lifted its position in InspireMD, Inc. (NYSE:NSPR - Free Report) by 70.6% during the third quarter, according to the company in its most recent filing with the Securities...

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

Stereotaxis (STXS) delivered earnings and revenue surprises of +5.21% and -5.55%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.20	--	--	N/A
Q1 '26	-$0.18	-$0.16	11.11%	BEAT
Q4 '25	-$0.19	-$0.14	27.59%	BEAT
Q3 '25	-$0.19	-$0.17	12.82%	BEAT
Q2 '25	-$0.26	-$0.26	--	EXPECTED

NSPR
InspireMD Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest NSPR News

NSPRInspireMD Inc